Clinical biochemistry of neuron specific enolase

Clinica Chimica Acta

Volumn 183, Issue 1, 1989, Pages 13-31

  Kaiser, E ^a   Kuzmits, R ^a   Pregant, P ^a   Burghuber, O ^a   Worofka, W ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Neural differentiation; Neuroblastoma; Neuroendocrine and paraneuronal cell; Neuron specific enolase; Seminoma; Small cell lung carcinoma; Tumor marker

Indexed keywords

NEURON SPECIFIC ENOLASE; TUMOR MARKER;

HUMAN; LUNG SMALL CELL CANCER; NEURAL DIFFERENTIATION; NEUROBLASTOMA; PRIORITY JOURNAL; REVIEW;

CARCINOMA, SMALL CELL; HUMAN; LUNG NEOPLASMS; NEOPLASMS; NERVOUS SYSTEM DISEASES; NEUROBLASTOMA; NEURONS; PHOSPHOPYRUVATE HYDRATASE; PRENATAL DIAGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0024370161     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-8981(89)90268-4     Document Type: Article

References (162)

1. Chromatographic and electrophoretic fractionation of soluble proteins of brain and liver
2. Brain specific proteins
3. The cellular localization of the two brain specific proteins, S-100 and 14-3-2
4. Regional changes in CNS levels of the S-100 and 14-3-2 proteins during development and ageing of the mouse
5. Immunocytochemical localization of nervous system specific proteins (NSP-R) in rat brain
6. Demonstration of enolase activity connected to the brainspecific protein 14-3-2
7. Determination and characterization of neuron specific protein (NSP) associated enolase activity
8. Enolase isoenzymes in rat tissue. Electrophoretic, Chromatographic, immuno-logical and kinetic properties
9. Enolase isoenzymes II. Hybridization studies, developmental and phylogenetic aspects
10. Evidence for a new form of enolase in rat brain
11. Enolase isoenzymes. III. Chromatographic and immunological characteristics of rat brain enolase
12. Human enolase isoenzymes: electrophoretic and biochemical evidence for three loci
13. Neuronal, nonneuronal and hybrid forms of enolase in brain: Structural, immunological and functional comparisons
14. Granule cell neurons in developing rat and monkey cerebellum change from glial to neuronal enolase
15. The brain enolase as specific markers of neuronal and glial cells
16. Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells
17. Developmental profile of neuron specific (NSE) and non-neuronal (NNE) enolase in rat and monkey brain
18. Changes in levels of translatable mRNS for neuron specific enolase and non-neuronal enolase during development of rat brain and liver
19. Developmental profile of three enolase isoenzymes in rat brain Determination from one cell embryo to adult brain
20. gaγ-enolase in the rat. Ontogeny and tissue distribution
21. Localization of neuron specific enolase in mouse spinal cord neurons grown in tissue culture
22. Neurons switch from non-neuronal (NNE) enolase to neuronal (NSE) enolase during development
23. Development of neuron-specific enolase immunoreactivity in avian nervous tissue in vivo and in vitro
24. Synapse formation is related to the onset of neuronspecific enolase immunoreactivity in the avian auditory and vestibular system
25. Human neuron specific enolase: genetic and developmental studies
26. Comparison of the usefulness of histochemistry and ultrastructural cytochemistry in the identification of neuroendocrine neoplasms
27. Immunological studies of a nerve specific protein
28. Measurement of neuron-specific (NSE) and nonneuronal (NNE) enolase in rat, monkey and human nervous tissues
29. A more sensitive radioimmunoassay for neuronspecific enolase suitable for cerebrospinal fluid determinations
30. Two-site column enzyme immunoassay for neuronspecific enolase (NSE) in human serum using monoclonal antibodies
31. Neuron-specific enolase. Assessment by ELISA in patients with small cell carcinoma of the lung
32. A bioluminescent assay for serum cerebrospinal fluid
33. Brain specific proteins: solid phase immunobioluminescence assay for neuron-specific enolase in human plasma
34. Determination of serum neuron-specific enolase by differential immunocapture
35. Rapid electrophoretic determination of neuronspecific enolase isoenzymes in serum
36. Purification, radioimmunoassay and distribution of human brain 14-3-2-protein (nervous system specific enolase) in human tissues
37. Immunoreactive nervous system specific enolase (14-3-2) protein in human serum and cerebrospinal fluid
38. Levels of immunoreactive aldolase C, creatine kinase-BB, neuronal and nonneuronal enolase, and 14-3-2 protein in circulating blood cells
39. Blood platelets contain a neurone specific enolase subunit
40. Tumor Biol
41. Neuron specific enolase: a useful diagnostic serum marker for small cell carcinoma of the lung
42. Neuron-specific enolase as a guide to the treatment of small cell lung cancer
43. NSE as a tumor marker
44. Radioimmunoassay development for human neuron-specific enolase: With some clinical results in lung cancer and neuroblastoma
45. Serum neuron-specific enolase as a marker useful for monitoring the effectiveness of therapy in patients with neuroblastoma — as compared with urinary catecholamine metabolites
46. Neurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cells
47. Neuron specific enolase is produced by neuroendocrine tumors
48. Neuron specific enolase in neuroendocrine tumors of the thymus, bronchia and skin
49. Neuron specific enolase in human small cell carcinoma cultures
50. Immunohistochemical localisation of neuron specific anolase (NSE) in small cell carcinomas and carcinoid tumours of the lung
51. Immunostaining of neuron-specific enolase is a valuable aid to the cytological diagnosis of neuroendocrine tumours of the lung
52. Neuron specific enolase: A marker for differential diagnosis of neuroblastoma and Wilms' tumor
53. Neuron-specific enolase in the diagnosis of neuroblastoma and other small round-cell tumors in children
54. Raised neuron-specific enolase in serum of children with metastatic neuroblastoma
55. Immunohistochemical localization of neuronspecific enolase in gastroenteropancreatic neuroendocrine tumors
56. Immunohisto-chemical detection of chromogranin and neuron-specific enolase in pancreatic endocrine neoplasms
57. Calcitonin, carcinoembryonic antigen and neuron-specific enolase in medullary thyroid carcinoma
58. Levels of enolase and other enzymes in the cerebrospinal fluid as indices of pathological changes
59. Neuron specific enolase as a marker of neuronal lesions during various comas in man
60. Severe head trauma and the changes of concentration of neuron specific enolase in plasma and in cerebrospinal fluid
61. Experimental brain ischemia: neuron specific enolase levels in cerebrospinal fluid as an index of neuronal damage
62. Neuronenspezifische Enolase und Schädel- Hirntrauma
63. Cerebrospinal fluid enolase in stroke
64. High neuron-specific enolase levels of cerebrospinal fluid in the early stage of Creutzfeldt-Jakob disease
65. Cerebrospinal fluid neuron-specific enolase is reduced in Alzheimer's disease
66. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system
67. The value of neuron specific enolase (NSE) in patients with brain tumors
68. Oat cell carcinoma of the lung. Its origin and relationship to bronchial carcinoid
69. Small-cell carcinoma of the lung
70. Neuroendocrine components of the broncho- pulmonary tract: hyperplasia, dysplasia, and neoplasms
71. Variable content of histamine, L-dopa decarboxylase and calcitonin in small cell carcinoma of the lung. Biologic and clinical implications
72. Establishment of continuous, clonable cultures of small-cell carcinoma of the lung which have amine precursor uptake and decarboxylation cell properties
73. Tumor products and potential tumor markers in small cell lung cancer
74. Diagnostic and therapeutic implications of ectopic hormone production in small cell carcinoma of the lung
75. Carcinoembryonic antigen for monitoring patients with small cell carcinoma of the lung during treatment
76. Human neurophysins as potential markers for small cell carcinoma of the lung: applications of specific radioimmunoassay
77. Hormonal polypeptides and amine metabolites in small cell carcinoma of the lung with special reference to stage and subtypes
78. Ectopic hormones in lung cancer patients at diagnosis and during therapy
79. ACTH, ADH, and calcitonin concentrations as markers for response and relapse in small cell carcinoma of the lung
80. Hormone production by cultures of small cell carcinoma of the lung
81. Multiple biologic markers in the monitoring of treatment for small cell carcinoma of the lung: the use of serial levels of plasma CEA and carbohydrates
82. Plasma calcitonin as a marker of disease activity in patients with small cell carcinoma of the lung
83. Immunostaining of neuron-specific enolase is a valuable aid to the cytological diagnosis of neuroendocrine tumours of the lung
84. Interconversion of biological characteristics of small cell lung cancer depending on culture conditions
85. Immunocytochemical demonstration of neuron-specific enolase (NSE) in human lung cancers
86. Enolase neurono-specific (NSE) in carcinomi bronchiali: studio immunoistochimico ed immunoenzimatico
87. Etude de 2 marqueurs, la keratine et la NSE dans les cancers bronchiques
88. Recent advances in the biology of small cell lung cancer
89. Serum neuron-specific enolase. A Marker for disease extent and response to therapy in small-cell lung cancer
90. Evaluation of serum neuron-specific enolase as a tumor marker for carcinoma of the lung
91. Potential utility of serum neuron-specific enolase levels in small cell carcinoma of the lung
92. Neuron specific enolase as a marker for neuroblastoma and small cell carcinoma of the lung
93. Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer
94. Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer
95. Neuronenspezifische Enolase — ein selektiver Marker des kleinzelligen Bronchialkarzinoms
96. Bedeutung der neurospezifischen Enolase (NSE) in der Diagnostik von Bronchialkarzinomen und neuroendokrinen Tumoren
97. Die Bestimmung der Tumor- marker NSE and CEA bei Patienten mit verschiedenen Lungenerkrankungen insbesondere Karzinomen
98. 2 cases of small cell carcinomas with elevation of serum neuron-specific enolase
99. Tumor markers in patients with lung cancer
100. 67Ga uptake ratio in small cell carcinoma of lung. With special reference to serum neuron-specific enolase and prognosis
101. Neuron-specific enolase (NSE) as a tumor marker and comparative evaluation with carcinoembryonic antigen (CEA) in small-cell lung cancer
102. Evaluation of γ-enolase as a tumor marker for lung cancer
103. Multiple sequential biomarkers in monitoring patients with carcinoma of the lung
104. Neuronspezifische Enolase (NSE) CEA and SCC — Eine sinnvolle Kombination von Tumormarkern beim Bronchialkarzinom
105. Role of biological markers and probes in lung carcinomas
106. Tumor lysis syndrome after induction chemotherapy of small-cell bronchogenic carcinoma
107. Differential expression of neutral isozymes by human medulloblastomas and gliomas and neuroectodermal cell lines
108. Serum neuron-specific enolase in children's cancer
109. Neuron-specific enolase in relation to differentiation in human neuroblastoma
110. Effect of nerve growth factor on the expression of colchicin-binding activity and 14-3-2 protein in an established line of human neuroblastoma
111. Selective changes in the phosphorylation of endogenous proteins in subcellular fractions from cyclic AMP-induced differentiated neuroblastoma cells
112. Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course
113. Higher levels of immunoreactive nervous system specific enolase in sera of patients with neuroblastoma
114. Nervous system-specific enolase in serum as a marker for neuroblastoma
115. Raised neuron-specific enolase in serum of children with metastatic neuroblastoma
116. Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course
117. Determination of urine neuron-specific enolase levels in an advanced neuroblastoma and two neuroblastoma patients
118. Urine neuron-specific enolase and its clinical implication in patients with neuroblastoma
119. Biologic differences between neuroblastoma Stage IVS and IV. Measurement of serum ferritin and E-rosette inhibition in 30 children
120. Serum neuron-specific enolase may be raised in children with Wilms' tumour
121. Serial determination of serum neuron-specific enolase in patients with neuroblastoma and other pediatrie tumors
122. A word of caution in the use neuron-specific enolase expression in tumor diagnosis
123. Prognostic factors in neuroblastoma
124. Serum ferritin as a guide therapy in neuroblastoma
125. Initial urinary catecholamine metabolizes and prognosis in neuroblastoma
126. Exocrine pancreatic tumors and their histological classification. A study based on 167 autopsy and 97 surgical cases
127. Immunocytochemical markers of uncommon pancreatic tumors
128. Acinar cell neoplasms of the exocrine pancreas
129. Morphogenesis of pancreatoblastoma; infantile carcinoma of the pancreas. Report of two cases
130. Solid and cystic acinar cell tumor of the pancreas
131. Recent advances in the diagnosis and treatment of insulinomas
132. Primary peptic ulcerations of the jejunum associated with islet cell tumors: twenty five year appraisal
133. Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia
134. Operative and chemotherapeutic management of glucagon producing tumors
135. Somatostatinoma syndrome biochemical morphologic and clinical features
136. Immunohistochemical study of neuron-specific enolase as a marker for islet cell and nerve tissue
137. Serum neuron-specific enolase: a serum marker for nonfunctioning pancreatic islet carcinoma
138. Medullary carcinoma of the thyroid gland. A clinicopathologic study of 40 cases
139. Fixed medullary and follicular carcinoma of the thyroid
140. Glandular (tubular and follicular) variants of medullary carcinoma of the thyroid
141. Cytopathologic features of medullary carcinoma of thyroid
142. Hypercalcitonemia in medullary carcinoma of the thyroid and malignancies Value of calcitonin as tumor marker
143. Détection immunocytochemique de calcitonine, d'ACTH, de BMSH, de β-endorphine et de somatostatine dans les carcinomes médullaires de la thyroide. Etude en immunoperoxidase (PAP, ABC) de 10 cas
144. Gastrointestinal polypeptides in patients treated for medullary carcinoma of the thyroid
145. Production of gastrin-releasing peptide by medullary carcinoma of the thyroid
146. Gastrin-releasing peptide in human neuroendocrine tumors
147. The values of calcitonin and carcinoembryonic antigen in the treatment and management of non-familial medullary thyroid carcinoma
148. Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid
149. Medullary carcinoma of the thyroid. An immunocytochemical and histochemical study of 25 cases using eight separate markers
150. Specific endocrine tissue marker defined by a monoclonal antibody
151. Silver impregnation and other immunocytochemical staining methods
152. The value of immunohistochemistry in medullary thyroid carcinoma. A systematic study of 30 cases
153. The role of biologic markers in testicular cancer
154. Serum tumor markers in patients with metastatic germ cell tumors of the testes A 10 year experience
155. Significance of human chorionic gonadotropin, alpha-fetoprotein, and pregnancy-specific beta-1-glycoprotein in the detection of tumor relapse and partial remission in 126 patients with nonseminomatous testicular germ cell tumors
156. Multiple biochemical tumor markers in seminoma. A double blind study
157. Placental alkaline phosphatase as a tumor marker in seminoma using H17E2 monoclonal antibody assay
158. Serum neuron-specific enolase. A marker for response to therapy in seminoma
159. Tumor markers in uremia: Carcinoembryonic antigen, neuronspecific enolase, carbohydrate antigen CA-50 and alpha-fetoprotein
160. Determination of neuron specific enolase in amniotic fluid and maternal serum for the prenatal diagnosis of fetal neural tube defects